Response to Soran et al.
作者信息
Reinhorn Daniel, Amir Eitan, Goldvaser Hadar
机构信息
Institute of Oncology, Rabin Medical Center, Petah-Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
出版信息
Breast. 2021 Dec;60:306-307. doi: 10.1016/j.breast.2021.10.007. Epub 2021 Oct 19.
Abstract
摘要
相似文献
1
Response to Soran et al.
Breast. 2021 Dec;60:306-307. doi: 10.1016/j.breast.2021.10.007. Epub 2021 Oct 19.
2
Reply to B. Ulaş Kahya et al and A. Soran et al.
J Clin Oncol. 2022 Nov 20;40(33):3899-3901. doi: 10.1200/JCO.22.00861. Epub 2022 Jul 12.
3
Hematolymphoid lesions of the breast.
Semin Diagn Pathol. 2017 Sep;34(5):462-469. doi: 10.1053/j.semdp.2017.05.007. Epub 2017 May 28.
4
Pericytes in Breast Cancer.
Adv Exp Med Biol. 2019;1147:93-107. doi: 10.1007/978-3-030-16908-4_3.
5
6
[Complex oncologic therapy for loco-regionally advanced breast cancer associated with long-lasting SARS-CoV-2 PCR-positivity].
Orv Hetil. 2021 Apr 7;162(16):611-614. doi: 10.1556/650.2021.32192.
7
Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer.
Clin Cancer Res. 2001 Apr;7(4):876-82.
8
Paravertebral Blocks Reduce Narcotic Use Without Affecting Perfusion in Patients Undergoing Autologous Breast Reconstruction.
Ann Surg Oncol. 2017 Oct;24(11):3180-3187. doi: 10.1245/s10434-017-6007-z. Epub 2017 Jul 17.
9
Perspectives in breast cancer treatment: APBI and breast-conserving surgery. In regard to Moran et al and Smith et al.
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):967. doi: 10.1016/j.ijrobp.2014.07.044. Epub 2014 Oct 18.
10
Mammographic density, MRI background parenchymal enhancement and breast cancer risk.
Ann Oncol. 2013 Nov;24 Suppl 8(Suppl 8):viii37-viii41. doi: 10.1093/annonc/mdt310.
本文引用的文献
1
Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis.
Breast. 2021 Aug;58:173-181. doi: 10.1016/j.breast.2021.05.003.
2
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial.
J Clin Oncol. 2021 Apr 1;39(10):1098-1107. doi: 10.1200/JCO.20.02447. Epub 2021 Feb 9.
3
Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer.
Ann Surg Oncol. 2021 Sep;28(9):5059-5070. doi: 10.1245/s10434-021-09650-3. Epub 2021 Feb 3.
4
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study.
Ann Surg Oncol. 2021 Sep;28(9):5048-5057. doi: 10.1245/s10434-021-09621-8. Epub 2021 Feb 2.
5
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
Ann Surg. 2019 Jun;269(6):1163-1169. doi: 10.1097/SLA.0000000000002771.
6
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3.
7
Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.
Ann Surg Oncol. 2018 Oct;25(11):3141-3149. doi: 10.1245/s10434-018-6494-6. Epub 2018 May 17.
8
A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017.
Jpn J Clin Oncol. 2012 Oct;42(10):970-3. doi: 10.1093/jjco/hys120. Epub 2012 Jul 24.
Zotero 插件